Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Terminated Phase 1 Trials for Yttrium Y-90 (DB13076)

IndicationStatusPhase
DBCOND0028499 (Recurrent Adult Diffuse Small Cleaved Cell Lymphoma)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01678443
Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid MalignanciesTreatment